IRIS
PELAIA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.037
AS - Asia 2.592
EU - Europa 1.266
SA - Sud America 932
AF - Africa 87
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.908
SG - Singapore 1.043
BR - Brasile 712
IT - Italia 661
CN - Cina 495
VN - Vietnam 450
IN - India 220
DE - Germania 167
HK - Hong Kong 129
AR - Argentina 89
GB - Regno Unito 81
FI - Finlandia 76
CA - Canada 56
BD - Bangladesh 53
NL - Olanda 47
MX - Messico 46
SE - Svezia 43
ID - Indonesia 42
EC - Ecuador 39
ES - Italia 29
IQ - Iraq 28
RU - Federazione Russa 28
FR - Francia 26
CO - Colombia 24
ZA - Sudafrica 23
VE - Venezuela 21
UA - Ucraina 19
AT - Austria 16
EG - Egitto 16
PY - Paraguay 16
TR - Turchia 16
PE - Perù 13
PL - Polonia 13
MA - Marocco 12
NP - Nepal 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
IE - Irlanda 10
JP - Giappone 10
CL - Cile 9
DO - Repubblica Dominicana 9
TW - Taiwan 9
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
SA - Arabia Saudita 8
TN - Tunisia 8
UY - Uruguay 8
AU - Australia 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
UZ - Uzbekistan 6
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
CH - Svizzera 4
CR - Costa Rica 4
EE - Estonia 4
IR - Iran 4
LT - Lituania 4
LV - Lettonia 4
PT - Portogallo 4
RO - Romania 4
AL - Albania 3
BG - Bulgaria 3
JM - Giamaica 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
GR - Grecia 2
HN - Honduras 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MR - Mauritania 1
NE - Niger 1
NI - Nicaragua 1
Totale 7.920
Salva come PNG Salva come JPEG
Città #
San Jose 659
Singapore 395
Dallas 374
Ashburn 305
Ho Chi Minh City 194
Santa Clara 191
Chandler 179
Bengaluru 164
Hefei 160
Hong Kong 125
Munich 103
Beijing 100
Hanoi 89
Milan 78
Princeton 68
Lawrence 67
São Paulo 64
Chicago 62
Turku 52
Catanzaro 48
London 47
Los Angeles 43
Wilmington 42
Boardman 38
Naples 32
Rome 30
Haiphong 28
Palermo 27
New York 23
Orem 22
Helsinki 21
Florence 20
Rio de Janeiro 19
Des Moines 18
Mexico City 18
Quito 18
San Nicola Manfredi 18
Council Bluffs 17
San Francisco 16
Thái Bình 16
Amsterdam 15
Biên Hòa 15
Johannesburg 15
Ninh Bình 15
Baghdad 14
Bari 13
Guayaquil 13
Porto Alegre 13
Brasília 12
Brooklyn 12
Buenos Aires 12
Redwood City 12
Warsaw 12
Alessandria 11
Belo Horizonte 11
Chennai 11
Troina 11
Catania 10
Curitiba 10
Olomouc 10
Paris 10
Redmond 10
Salvador 10
Guarulhos 9
Lima 9
Montreal 9
Norwalk 9
Ottawa 9
Seattle 9
Atlanta 8
Denver 8
Dublin 8
Galbiate 8
Hải Dương 8
Mascalucia 8
Thái Nguyên 8
Tokyo 8
Toronto 8
Asunción 7
Da Nang 7
Hanover 7
Messina 7
Montevideo 7
Mumbai 7
Nairobi 7
The Dalles 7
Ankara 6
Bogotá 6
Boston 6
Buffalo 6
Can Tho 6
Castrovillari 6
Caxias do Sul 6
Manaus 6
Osasco 6
Phoenix 6
Ribeirão Preto 6
Santo André 6
Stockholm 6
São Bernardo do Campo 6
Totale 4.533
Salva come PNG Salva come JPEG
Nome #
Patient-derived 3D nasal spheroids reveal epithelial changes following Dupilumab therapy in CRSwNP: a preliminary report 152
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 124
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 98
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 97
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 91
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 81
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 81
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 77
Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP 75
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 75
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 75
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 73
Type 2 severe asthma: pathophysiology and treatment with biologics 71
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 70
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 70
Association Between Sleep Apnea and Valvular Heart Diseases 69
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 67
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 66
MALDI MS-Based Investigations Targeting SARS-CoV-2 66
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 65
Clinical remission in severe asthma: lights and shadows on an ambitious goal 65
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 64
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 64
Device for Performing Spirometry in Total Laryngectomized Patients 63
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 63
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 62
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 62
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 61
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 61
Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. 60
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 60
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade 59
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 59
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 59
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 58
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 58
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 57
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 57
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 56
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 56
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 55
Emerging biological treatments for asthma 55
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 55
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 55
Biologics in severe asthma 55
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 54
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 54
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 54
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 54
Switching Biological Therapies in Severe Asthma 53
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies 53
Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. 53
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 53
Oxygenation strategies during flexible bronchoscopy: a review of the literature 53
Effect of continuous positive airway pressure on non-fatal stroke and paroxysmal atrial fibrillation recurrence in obstructive sleep apnoea elderly patients 53
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers 52
Maxillary sinus mucocele with orbital complications 52
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 52
Patient-ventilator asynchrony in adult critically ill patients 52
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 51
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 51
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 51
Tissue microRNA dynamics in sinonasal inverted papilloma: implications for pathology and therapy 50
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study 50
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 50
Phenotyping severe asthma: a rationale for biologic therapy 50
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 50
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 50
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 49
Allergy clinics in times of the SARS-CoV-2 pandemic: An integrated model 49
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 49
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 49
Adherence to omalizumab: A multicenter “real-world” study 49
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 48
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 48
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 48
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 48
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 48
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 48
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 47
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 47
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 47
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 46
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 46
Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma 46
Interleukin-5 in the Pathophysiology of Severe Asthma 46
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 46
Tezepelumab: A potential new biological therapy for severe refractory asthma 46
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 46
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 46
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease 45
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 45
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics 44
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 44
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 44
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 44
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life 44
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 44
Are Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from 8 Italian Centers 44
Novel Biological Therapies for Severe Asthma Endotypes 43
Totale 5.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022242 5 5 33 34 7 8 22 40 29 22 36 1
2022/2023625 141 33 41 25 61 56 26 54 85 30 52 21
2023/2024390 68 46 34 28 13 76 6 18 6 26 24 45
2024/20251.637 169 19 27 34 190 215 109 50 164 52 254 354
2025/20265.065 237 494 773 1.012 465 232 541 245 542 361 118 45
Totale 8.170